1. Home
  2. BNR vs AXIL Comparison

BNR vs AXIL Comparison

Compare BNR & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • AXIL
  • Stock Information
  • Founded
  • BNR 2014
  • AXIL 2015
  • Country
  • BNR China
  • AXIL United States
  • Employees
  • BNR N/A
  • AXIL N/A
  • Industry
  • BNR Medical Specialities
  • AXIL Package Goods/Cosmetics
  • Sector
  • BNR Health Care
  • AXIL Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • AXIL Nasdaq
  • Market Cap
  • BNR 29.1M
  • AXIL 29.2M
  • IPO Year
  • BNR 2020
  • AXIL N/A
  • Fundamental
  • Price
  • BNR $3.25
  • AXIL $6.10
  • Analyst Decision
  • BNR
  • AXIL
  • Analyst Count
  • BNR 0
  • AXIL 0
  • Target Price
  • BNR N/A
  • AXIL N/A
  • AVG Volume (30 Days)
  • BNR 68.1K
  • AXIL 7.2K
  • Earning Date
  • BNR 06-02-2025
  • AXIL 04-08-2025
  • Dividend Yield
  • BNR N/A
  • AXIL N/A
  • EPS Growth
  • BNR N/A
  • AXIL 93.65
  • EPS
  • BNR N/A
  • AXIL 0.29
  • Revenue
  • BNR $70,669,261.00
  • AXIL $27,007,463.00
  • Revenue This Year
  • BNR $136.32
  • AXIL N/A
  • Revenue Next Year
  • BNR N/A
  • AXIL N/A
  • P/E Ratio
  • BNR N/A
  • AXIL $21.16
  • Revenue Growth
  • BNR N/A
  • AXIL N/A
  • 52 Week Low
  • BNR $2.18
  • AXIL $3.54
  • 52 Week High
  • BNR $7.90
  • AXIL $11.49
  • Technical
  • Relative Strength Index (RSI)
  • BNR 57.77
  • AXIL 47.23
  • Support Level
  • BNR $2.49
  • AXIL $6.08
  • Resistance Level
  • BNR $3.05
  • AXIL $6.71
  • Average True Range (ATR)
  • BNR 0.34
  • AXIL 0.48
  • MACD
  • BNR 0.15
  • AXIL -0.03
  • Stochastic Oscillator
  • BNR 87.61
  • AXIL 9.35

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About AXIL AXIL Brands Inc. Common Stock

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.

Share on Social Networks: